These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 9157179
1. Release of Type II phospholipase A2 immunoreactivity and phospholipase A2 enzymatic activity from human placenta. Farrugia W, Rice GE, Wong MH, Scott KF, Brennecke SP. J Endocrinol; 1997 Apr; 153(1):151-7. PubMed ID: 9157179 [Abstract] [Full Text] [Related]
4. Type II phospholipase A2 in human gestational tissues: extractable immuno- and enzymatic activity in fetal membranes. Aitken MA, Farrugia W, Wong MH, Scott KF, Brennecke SP, Rice GE. Biochim Biophys Acta; 1993 Nov 03; 1170(3):314-20. PubMed ID: 8218351 [Abstract] [Full Text] [Related]
5. Secretory type II PLA2 immunoreactivity and PLA2 enzymatic activity in human gestational tissues before, during and after spontaneous-onset labour at term. Munns MJ, Farrugia W, King RG, Rice GE. Placenta; 1999 Jan 03; 20(1):21-6. PubMed ID: 9950141 [Abstract] [Full Text] [Related]
6. Contribution of type II PLA2 to prostaglandin formation: a study using a type II PLA2 specific inhibitor SB 203347. Munns MJ, King RG, Rice GE. Prostaglandins Other Lipid Mediat; 1999 Jul 03; 57(5-6):361-70. PubMed ID: 10480490 [Abstract] [Full Text] [Related]
7. Bacterial endotoxin increases type II phospholipase A2 immunoreactive content and phospholipase A2 enzymatic activity in human choriodecidua. Nguyen HT, Rice GE, Farrugia W, Wong M, Brennecke SP. Biol Reprod; 1994 Mar 03; 50(3):526-34. PubMed ID: 8167224 [Abstract] [Full Text] [Related]
8. Type II phospholipase A2 in human gestational tissues: subcellular distribution of placental immuno- and catalytic activity. Farrugia W, Aitken MA, van Dunné F, Wong MH, Brennecke SP, Scott KF, Rice GE. Biochim Biophys Acta; 1993 Feb 10; 1166(1):77-83. PubMed ID: 8431495 [Abstract] [Full Text] [Related]
12. Differential expression of type II, IV and cytosolic PLA2 messenger RNA in human intrauterine tissues at term. Freed KA, Moses EK, Brennecke SP, Rice GE. Mol Hum Reprod; 1997 Jun 10; 3(6):493-9. PubMed ID: 9239738 [Abstract] [Full Text] [Related]
13. Relative abundance of human placental phospholipase A2 messenger RNA in late pregnancy. Aitken MA, Rice G, Brennecke S. Prostaglandins; 1992 Apr 10; 43(4):361-70. PubMed ID: 1376934 [Abstract] [Full Text] [Related]
14. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents. Munns MJ, King RG, Rice GE. Clin Exp Pharmacol Physiol; 1999 Mar 10; 26(3):230-5. PubMed ID: 10081619 [Abstract] [Full Text] [Related]
15. Membranes exert indirect negative control on phospholipase A2 in human placenta. Buhl WJ, Zipfel M, Garcia MT, Eisenlohr LM, Gehring U. Eicosanoids; 1991 Mar 10; 4(4):235-44. PubMed ID: 1790000 [Abstract] [Full Text] [Related]
19. Activation of cytosolic phospholipase A2 in permeabilized human neutrophils. Bauldry SA, Wooten RE, Bass DA. Biochim Biophys Acta; 1996 Jan 19; 1299(2):223-34. PubMed ID: 8555268 [Abstract] [Full Text] [Related]
20. Regulation of phospholipase isozymes by nuclear factor-kappaB in human gestational tissues in vitro. Lappas M, Permezel M, Georgiou HM, Rice GE. J Clin Endocrinol Metab; 2004 May 19; 89(5):2365-72. PubMed ID: 15126565 [Abstract] [Full Text] [Related] Page: [Next] [New Search]